Clinical trial
A Study of DU-176b in Preventing Blood Clots After Hip Replacement Surgery
NCT00398216 · Daiichi Sankyo, Industry · Completed
Key facts
| NCT number | NCT00398216 |
|---|---|
| Title | A Study of DU-176b in Preventing Blood Clots After Hip Replacement Surgery |
| Official title | A Phase IIb, Randomized, Parallel Group, Double-Blind, Double-Dummy, Multi-Center, Multi-National, Multi-Dose, Study of DU-176b Compared to Dalteparin in Patients Undergoing Elective Unilateral Total Hip Replacement |
| Lead sponsor | Daiichi Sankyo, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Thrombosis, Hip Replacement |
| Intervention type | Drug |
| Interventions | DU176b - action is the prevention of venous thromboembolism by the use of a Factor Xa inhibitor |
| Enrollment | 903 |
| Start date | May 1, 2006 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Nov 10, 2006 |
| Last update posted | Feb 26, 2019 |
| Countries | Canada, Denmark, Hungary, Latvia, Russia, Ukraine, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: